Clinical Trials

36 enrolled 14 charts

Carcinoma, Transitional Cell

NCT05522257 2024-12-09

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

25 enrolled

GenitourinarySarcoma

Carcinoma, Transitional Cell, Sarcoma

NCT03534804 2024-11-26

PemCab

37 enrolled 27 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03658304 2024-11-05

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

29 enrolled 11 charts

Carcinoma, Transitional Cell

NCT03557918 2024-07-03

Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer

26 enrolled 14 charts

Carcinoma, Transitional Cell

NCT02451423 2024-05-31

Neoadjuvant Atezolizumab in Localized Bladder Cancer

23 enrolled 14 charts

Carcinoma, Transitional Cell

NCT03590054 2024-03-22

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

DermatologicGenitourinaryHead & NeckThoracic

35 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ureteral Neoplasms

NCT05700344 2024-02-29

SOGUG

125 enrolled

Carcinoma, Transitional Cell

NCT03511391 2024-01-23

CHEERS

DermatologicGenitourinaryHead & NeckThoracic

99 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT06193941 2024-01-09

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

400 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06169904 2023-12-14

B7-Family Score in Urothelial Carcinoma

215 enrolled

Carcinoma, Transitional Cell

NCT04535921 2023-12-11

Fear of Cancer Recurrence in Genitourinary Cancer

500 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Prostatic Neoplasms, Testicular Neoplasms

NCT02795156 2023-12-05

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

100 enrolled 14 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

NCT05154084 2023-11-14

RESECT

19,505 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03390595 2023-10-18

INDUCOMAIN

85 enrolled

Carcinoma, Transitional Cell

NCT02643043 2023-09-29

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

219 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT03677544 2023-05-17

CYSTECTOMEN

748 enrolled

Carcinoma, Transitional Cell

NCT03758781 2023-04-14

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

GenitourinaryHead & NeckThoracic

12 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Neoplasm Metastasis, Recurrence

NCT03689192 2023-02-28

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

13 enrolled 10 charts

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Colorectal Neoplasms

NCT02581982 2023-01-10

Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer

27 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03464734 2022-11-30

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

70 enrolled

Carcinoma, Transitional Cell

NCT00805129 2022-11-25

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium

46 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00623831 2022-10-25

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

17 enrolled 14 charts

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Gastrointestinal Stromal Tumors

NCT03584659 2022-10-25

iBLAD

230 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00070070 2022-10-12

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

6 enrolled 7 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02500121 2022-09-30

Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer

108 enrolled 15 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04077359 2022-09-06

PROTEHCT

300 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Nephrolithiasis

NCT04197089 2022-08-03

VitDURO

Phase 4 Completed

2 enrolled

Carcinoma, Transitional Cell, Neoplasms

NCT05070039 2022-07-15

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

40 enrolled

Carcinoma, Transitional Cell

NCT01524991 2022-07-11

First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma

36 enrolled 12 charts

Carcinoma, Transitional Cell

NCT01780545 2022-07-11

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

200 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03945084 2022-05-23

Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy

58 enrolled

Phase EARLY_PHASE1 Completed

Carcinoma, Transitional Cell

NCT03071328 2022-04-11

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

10 enrolled